Overview
Nike announced a change in its chief financial officer, naming former Pfizer finance chief David Denton as executive vice president and chief financial officer, effective August 17, 2026. Denton will replace Matt Friend, who will remain with Nike until September 4, 2026, to ensure a transition period.
Analyst Reaction and Rating Change
Evercore ISI, the brokerage firm, downgraded Nike’s rating from Outperform to In‑line on the same day. The downgrade was driven by a combination of deteriorating channel checks, weak momentum in lifestyle and family retail channels, an underwhelming performance of recent Jordan retro shoe launches, and supply‑chain disruptions in Europe that have affected deliveries of World Cup‑related products.
Guidance and Earnings Outlook
Investors continue to focus on Nike’s prior guidance that first‑half fiscal 2027 revenue will decline by a low‑single‑digit percentage. Evercore cautioned that even a modest deviation from this outlook could place pressure on the stock price. The firm also highlighted that the timing of the CFO transition—mid‑August—could complicate preparations for Nike’s anticipated fall analyst day, which CEO Elliott Hill indicated is expected to take place in November. Evercore expressed concern that a CFO joining only a few weeks before the event may not become sufficiently familiar with the business to effectively present a multi‑year strategic plan.
Potential Earnings Reset
Given the heightened uncertainties, Evercore noted an increased probability of a meaningful earnings cut before the investor day. Analysts suggested that management might need to lower expectations ahead of the event to avoid disappointing investors.
Market Reaction
Following the CFO announcement, Nike shares closed the regular session down 1.9% at $42.38. In extended trading, the stock rebounded, rising 0.8% to $42.73.
Publication Details
The article was published on 24 June 2026 at 07:48 am by Investing.com, citing Reuters reporting by Roushni Nair.